Stocks · News reference
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Hugging Face’s Microduck robot generated more than $2.6 million in orders within 24 hours, highlighting surging interest in AI robotics.
Read original at benzingaNvidia has built a $63.4 billion portfolio of AI infrastructure partners including Intel, SpaceX, CoreWeave, and Synopsys. As energy becomes a critical bottleneck for AI data center growth, Bloom Energy—a hydrogen fuel-cell company that recently crossed $1 billion in quarterly revenue and signed a $25 billion partnership with Brookfield Asset Management—emerges as a potential candidate for Nvidia investment.
Read original at the-motley-foolNvidia's data center business generated $89.0 billion in Q2 FY2027, representing 92.5% of total revenue. Based on current guidance and growth trends, analyst Daniel Sparks predicts the data center division will exceed $100 billion in quarterly revenue by the end of fiscal 2027 in January, with the October quarter having a decent chance of reaching this milestone first. The prediction relies on maintaining current revenue mix and Nvidia meeting its $108 billion guidance for Q3.
Read original at the-motley-foolA list from Time says Bernie Sanders, Paris Hilton and Ben Affleck are more influential to AI than Nvidia CEO Jensen Huang.
Read original at benzingaThe global breast cancer therapeutics market is projected to grow from USD 39.46 billion in 2025 to USD 95.14 billion by 2035, with a CAGR of 9.20%. Growth is driven by increased adoption of targeted therapies, CDK4/6 inhibitors, immunotherapy, and antibody-drug conjugates. North America leads with 38.61% market share, while Asia Pacific shows the fastest growth. Targeted therapy dominates with 64.85% share, while immunotherapy is the fastest-growing segment at 14.25% CAGR.
Read original at globenewswire-incFDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.
Read original at benzinga